- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05211297
Impact of Suspected Preterm Labour on Cardiometabolic Profile and Neurodevelopment (SKs)
Impact of Suspected Preterm Labour During Pregnancy on Cardiometabolic Profile and Neurodevelopment During Childhood: a Prospective Cohort Study Protocol.
Suspected preterm labour (SPL), define as the presence of regular and painful uterine contractions and cervical shortening, constitute a prenatal insult with potential long-term consequences. However, despite recent evidence demonstrating a suboptimal neurodevelopment at 2 years in this population, it remains under-recognized as a significant risk factor for neurodevelopmental disorders or other chronic diseases. The objective of this study is to assess the impact of suspected preterm labour during pregnancy on cardiometabolic profile and neurodevelopment during childhood (6-8 years).
Prospective cohort study including children whose mothers suffered a suspected preterm labor during pregnancy and paired controls. A neurodevelopment, cardiovascular and metabolic assessment at 6-8 years of age will be performed. A trained psychologist will carry out the neurodevelopment assessment. Body composition and physical fitness assessment will be performed by one trained pediatrician and nurse. Finally, cardiovascular assessment, including echocardiography and blood pressure, will be performed by two pediatric cardiologists. Data regarding perinatal and postnatal characteristics, diet, lifestyle and weekly screen time of the child will be obtained from clinical histories and direct interviews with the families. Primary outcome measures will include body mass index and adiposity, percentage of fat mass and total and regional lean mass, bone mineral content and density, cardio-respiratory resistance, isometric muscle strength, dynamic lower body strength, systolic and diastolic blood pressure, left ventricle (LV) systolic and diastolic function, general intelligence index, visuospatial working memory span, visual development test, visual acuity, index of emotional and behavioral problems.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Aragón
-
Zaragoza, Aragón, Spain, 50009
- Cristina Paules
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Two cohorts of children at 6-8 years of age:
A. Exposed cohort: children whose mothers suffered a suspected preterm labour during pregnancy. They are subdivided into:
- Moderate-late preterm births (between 32 and 37 weeks of gestation)
- "False suspected preterm labour" (full-term births (> 37 weeks) after suffering a suspected preterm labour) B. Unexposed cohort: children born at term (> 37 weeks) whose mothers did not suffer a suspected preterm labour during pregnancy.
Description
Inclusion Criteria:
- Singleton pregnancy
- Good understanding and sign of informed consent.
Exclusion Criteria:
- Multiple pregnancy
- Malformations
- Chromosomal diseases
- Prenatal infections
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Exposed cohort:
Children whose mothers suffered a suspected preterm labour during pregnancy.
|
|
Unexposed cohort
Children born at term (> 37 weeks) whose mothers did not suffer a suspected preterm labour during pregnancy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of fat mass and total and regional lean mass
Time Frame: 6-8 years
|
6-8 years
|
|
|
Body mass index and adiposity
Time Frame: 6-8 years
|
6-8 years
|
|
|
Cardio-respiratory resistance
Time Frame: 6-8 years
|
After fitting the safety harness, the test began when the participants were able to walk easily on the treadmill (Quasar Med 4.0, h/p/cosmos, Nußdorf, Germany).
The protocol started with a speed of 2.4 km/h, increasing by 0.8 km/h every 2 min until the participants were unable to walk or reached a speed of 4.8 km/h.
Then, the slope was increased by 4% every minute until exhaustion or up to a maximal slope of 24%.
The respiratory gas exchange data were measured breath-by-breath using open-circuit spirometry (Oxycon Pro, Jaeger/Viasys Healthcare, Hoechberg, Germany).
Maximal oxygen uptake (VO2max) values were averaged over consecutive 15 s periods.
|
6-8 years
|
|
Systolic and diastolic blood pressure
Time Frame: 6-8 years
|
6-8 years
|
|
|
Left ventricle (LV) systolic and diastolic function
Time Frame: 6-8 years
|
End-diastolic and end-systolic diameter, septum and posterior wall thickness, heart rate, ejection fraction (by Teicholz and biplane Simpson methods), mitral annulus S´ wave velocity (tissue doppler), mitral annulus E and A waves velocity (pulse-wave doppler), E´ and A´ waves velocity (tissue doppler), TEI index (tissue doppler) and LV strain and strain rate at three apical views (speckle tracking).
|
6-8 years
|
|
General intelligence index
Time Frame: 6-8 years
|
6-8 years
|
|
|
Visual development test
Time Frame: 6-8 years
|
6-8 years
|
|
|
Global index of problems
Time Frame: 6-8 years
|
6-8 years
|
|
|
Index of emotional problems
Time Frame: 6-8 years
|
6-8 years
|
|
|
Index of behavioral problems
Time Frame: 6-8 years
|
6-8 years
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Cristina Paules, IISAragon . Clini Hospital Zaragoza.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Superkids study
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.